Category: SeaPRwire

New York, NY – February 01, 2026 – (SeaPRwire) – Recently, the world’s only Pokémon card graded PSA 10 – Pikachu Illustrator – once again became a focal point of global attention across the collectibles and cultural landscape. As a long-term contributor to TCG infrastructure and the broader collectibles ecosystem, The Collectors Grid(TCG.Zone) participated in and witnessed this historically significant moment. Recognized as one of the most iconic works in Pokémon card history, Pikachu Illustrator is distinguished not only by its extreme rarity, but also by its symbolic representation of Pokémon culture, artistic value, and generational memory. The Legendary Status of the World’s Only PSA 10 According to publicly available information, the world’s only PSA 10 “Pikachu Illustrator” card is currently owned by Logan Paul. The card was involved in a high-profile transaction in 2022, valued at nearly USD 5.3 million, marking a defining milestone in the history of Pokémon card collecting. The Industry Significance of Goldin Auctions Although Logan Paul’s acquisition of the card did not take place through Goldin, the Goldin auction platform has continued to play an important role in the card’s contemporary circulation and visibility. As one of the world’s most influential high-end collectibles auction platforms, Goldin’s auction framework and the attention it generates brought renewed global focus to this legendary card, further positioning Pokémon cards within the broader mainstream collectibles market. Netflix Documentary Captures a Cultural Moment Amid the phenomenon-level attention generated by this card on the Goldin platform, Netflix documented the full auction process and produced a dedicated documentary. Approached from a cultural and historical perspective, the documentary highlights the unique position of Pikachu Illustrator within the modern collectibles ecosystem, elevating it beyond price alone and framing it as a lasting cultural reference. Global Participation and TCG.Zone’s Involvement The discussions and auction activity surrounding Pikachu Illustrator attracted participation from top collectors, institutions, and professional teams from around the world. TCG.Zone was among the active participants in the bidding process. During the auction, TCG.Zone submitted a bid of USD 5,000,000. Although the bid was ultimately surpassed by a higher offer, TCG.Zone remained deeply engaged throughout the process and witnessed this pivotal moment firsthand. Continuing to Follow the Card’s Future Trajectory In post-auction interviews, TCG.Zone stated that this participation does not mark an endpoint. The team will continue to closely monitor the movement and future trajectory of the world’s only PSA 10 Pikachu Illustrator, and does not rule out participating again should the right opportunity arise. This event represents more than an auction. It stands as a collective reflection on rarity, cultural identity, and long-term value. The story of Pikachu Illustrator continues to unfold,and remains an enduring chapter in the global history of Pokémon card collecting. Social Links Twitter: https://x.com/tcgzoneofficial Instagram: https://www.instagram.com/tcgzoneofficial/ Telegram: https://t.me/tcgzoneofficial Media Contact Brand : The Collectors Grid (tcg.zone) Contact: Annie Email: hi@tcg.zone Website: https://www.tcg.zone

SHENZHEN, Jan 30, 2026 – (ACN Newswire via SeaPRwire.com) – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement published by the Group on 22 April 2025 for details) received approval from the National Medical Products Administration of China (NMPA) on 30 January 2026 for the New Drug Application (NDA) of ruxolitinib phosphate cream (the “Product”) for the treatment of non-segmental vitiligo with facial involvement in children aged 12 years and older and adult patients. It is the first and only targeted drug approved in China for vitiligo, addressing a significant unmet clinical need. Ruxolitinib phosphate cream is the first and only drug approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for repigmentation in nonsegmental vitiligo[1,2]. Prior to receiving formal NDA approval, the Group benefited from the “Early and Pilot Implementation” policy granted to the Hainan Free Trade Port and Lecheng Pilot Zone (“Lecheng Pilot Zone”), the “Hong Kong and Macau Medicine and Equipment Connect” policy, and the clinically urgently needed imported drug policies of the Beijing and Tianjin Free Trade Zones, and had already initiated the pilot application of ruxolitinib phosphate cream. Currently, Boao Super Hospital has prescribed ruxolitinib phosphate cream to over 7,000 patients with non-segmental vitiligo, and more than twenty hospitals in Guangzhou, Shenzhen, Dongguan, Foshan, Zhongshan, Zhuhai, Jiangmen, Huizhou, Beijing and Tianjin have provided prescription services for the Product, demonstrating its clinical potential. The product has shown positive results in both overseas clinical studies and the real-world study in China: in two identical Phase III double-blind, randomized, placebo-controlled studies (TRuE-V1 and TRuE-V2) conducted overseas, the proportion of patients achieving the primary efficacy endpoint of at least 75% improvement in the Facial Vitiligo Area Score Index (F-VASI 75) after 24 weeks of treatment with ruxolitinib phosphate cream was 29.9% in both studies, significantly higher than the 7.5% and 12.9% in the placebo groups, respectively. Continued use up to 52 weeks showed sustained repigmentation[3]. In accordance with the relevant regulations of the Lecheng Pilot Zone’s real-world data application pilot project, ruxolitinib phosphate cream underwent real-world study in China, demonstrating positive efficacy consistent with the results of overseas pivotal clinical studies. All secondary efficacy endpoints in both domestic and overseas clinical studies showed a benefit trend consistent with the primary efficacy endpoint, and the treatment effect for vitiligo continued to improve with prolonged treatment. Furthermore, according to safety monitoring data from the Lecheng Pilot Zone, no new safety event was identified, no adverse event (AE) leading to discontinuation or withdrawal of treatment occurred, and no study drug-related serious adverse event (SAE) occurred. This approval in vitiligo brings new hope for treatment to over 10 million vitiligo patients in China, addressing urgent clinical needs. At the same time, it will add to Dermavon’s product portfolio in the field of skin treatment, potentially synergizing with Dermavon’s commercialized innovative drug ILUMETRI (tildrakizumab injection), commercialized exclusive drug Hirudoid (mucopolysaccharide polysulfate cream), and a series of innovative drugs under development and dermatological skin care products, in terms of expert network and market resources, thereby potentially enhancing Dermavon’s position in the field of skin health. Furthermore, the Phase III clinical trial in China of ruxolitinib phosphate cream for the treatment of mild to moderate atopic dermatitis (AD) has achieved positive results. Currently, the Group is actively advancing the NDA for ruxolitinib phosphate cream for the treatment of AD in China, which, if approved, will provide a new treatment option for a broader patient population with AD in China. About Vitiligo Vitiligo is a chronic autoimmune disease characterized by depigmentation of the skin, which results from the loss of pigment-producing cells known as melanocytes. It is estimated that there are approximately 10.3 million vitiligo patients in China and non-segmental vitiligo patients account for approximately 8.2 million[4]. Existing therapies, such as topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs), have clinical limitations, with adverse reactions or limited efficacy with long-term use. The NDA approval of ruxolitinib phosphate cream successfully fills the gap in targeted drug treatment for vitiligo and is of great landmark significance. More About Ruxolitinib Phosphate Cream Ruxolitinib phosphate cream (Opzelura®), a novel cream formulation of the selective JAK1/JAK2 inhibitor ruxolitinib developed by Incyte, is approved for the topical treatment of nonsegmental vitiligo in adult and patients aged 12 years and older, and for the short-term and non-continuous chronic treatment of mild to moderate AD in patients aged 2 years and older without immunodeficiency in the U.S. In Europe, ruxolitinib phosphate cream is approved for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age. The Group, through a subsidiary of Dermavon entered into a Collaboration and License Agreement with Incyte for ruxolitinib phosphate cream on 2 December 2022, obtaining an exclusive license to develop, register and commercialize the Product in Mainland China, Hong Kong Special Administrative Region, Macau Special Administrative Region, Taiwan Region and eleven Southeast Asian countries (the “Territory”) and a non-exclusive license to manufacture the Product in the Territory. The subsidiary of Dermavon has sublicensed the relevant rights for the Product outside Mainland China to the Group (excluding Dermavon and its subsidiary). Incyte has worldwide rights for the development and commercialization of ruxolitinib phosphate cream, marketed in the United States and Europe as Opzelura®. Opzelura® and the Opzelura® logo are registered trademarks of Incyte. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group. Reference: 1. The U.S. FDA approval information can be found on the Incyte official website, as follows: https://investor.incyte.com/news-releases/news-release-details/incyte-announces-us-fda-approval-opzeluratm-ruxolitinib-cream 2. The EMA approval information can be found on the Incyte official website, as follows: https://investor.incyte.com/news-releases/news-release-details/incyte-announces-european-commission-approval-opzelurar 3. The clinical studies information can be found on the Opzelura® official website, as follows: https://www.opzelura.com/opzelura-prescribing-information 4. China Insights Consultancy’s industrial report CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/

Moscow, Russia – January 31, 2026 – (SeaPRwire) – Expert Dialogues were held for the first time within the Open Dialogue framework at the Russia National Centre in Moscow on 30 January. The forum focused on five major megatrends shaping global economic, technological, and social development, bringing together international experts to explore how these forces will influence societies and industries in the decades ahead. Organized by the Russia National Centre in partnership with the Centre for Cross-Industry Expertise “The Third Rome” and supported by the Presidential Executive Office, the forum brought together experts from around the world to discuss economic, technological, and social transformations. Maksim Oreshkin, Deputy Head of the Russian Executive Administration for Global Trends, presented five key megatrends that, he said, are already shaping global development and will continue to influence the world in the coming decades. “By 2026, Open Dialogue has become an international platform uniting experts from across the world to discuss the future of the planet, the global economy, and society,” Oreshkin said. “Understanding these processes is essential for preparing for change and leveraging it in the interests of nations and, above all, people. Today, I will focus on five key megatrends — while not treating artificial intelligence as a separate trend, because it has already become an integral part of our lives.” 1. A New Global Economic Paradigm: Globalisation 2.0 A shift from traditional globalisation to a more decentralised system was described. BRICS+ countries now play a growing role in the global economy, technological development, and demographic trends, while the Global South is increasingly engaging in direct trade and national-currency settlements. “Globalisation hasn’t ended; it has changed,” Oreshkin said. “Sovereignty — at state, social, and economic levels — is now the key to competitiveness. Only countries that preserve all three levels can lead in a multipolar world.” China, the USA, India, and Russia are identified as major global powers, while highlighting emerging growth centres such as Indonesia and “connector countries” like the United Arab Emirates. Digital platforms and decentralised networks are also becoming independent participants in the world economy. 2. Platformisation and Institutional Automation The second megatrend highlights the rise of platforms and automation across all sectors. Platforms and algorithms are increasingly shaping decision-making in healthcare, education, finance, trade, and beyond. “Platform solutions enhance efficiency and reduce transaction costs through self-adjusting algorithms,” Oreshkin said. “Countries without technological sovereignty risk becoming dependent on external platforms, which can have strategic consequences during conflicts.” 3. Transformation of the Global Financial System It was noted that traditional financial models face mounting challenges, including rising public debt, widening inequality, and geopolitical fragmentation. Technologies such as blockchain, artificial intelligence, and digital platforms are creating alternative financial mechanisms, including decentralised finance. “The traditional model of cross-border payments is under pressure. Decentralised systems and digital technologies are reshaping the financial system,” he said. 4. Demographic Shifts and Challenges The fourth megatrend concerns global population dynamics. Global fertility rates have fallen sharply, with some countries facing critical declines. By the end of the 21st century, the working-age population may shrink significantly, while the proportion of elderly people rises, placing pressure on pension systems and social services. “Even in Africa, the ratio of elderly to working-age population will rise to 30%, and globally to 56%,” Oreshkin explained. “Education demand will decrease, but healthcare and social service needs will grow. These interconnected trends will amplify each other.” 5. Human Capital Development in the Technological Era The final megatrend focuses on human capital in a rapidly changing technological environment. Autonomous systems, digital platforms, and artificial intelligence are transforming education, work, and healthcare, while biotechnologies expand human capabilities. “AI is both a challenge and an opportunity,” Oreshkin said. “It allows personalized learning paths and supports teachers. Professions are changing: mid-level specialists will be in demand, and companies must retrain employees from junior positions. The social sphere will also evolve, ensuring active longevity in the new demographic era.” Global Perspective Throughout the presentation, Oreshkin illustrated each trend with real-life examples from different continents: a manager from Asia, a farmer from Africa, and a homemaker from Eastern Europe. He highlighted that innovations in Africa could improve education and healthcare, Eastern Europe may see rising living standards and more efficient social systems, and Asia will require reskilling to meet changing labor demands. “The world has entered a period of significant change in finance, demography, and other spheres. States, companies, and individuals must be prepared. Those who understand and adapt will shape the future,” Oreshkin concluded. Open Dialogue on Air This year, Open Dialogue introduced a podcast format — Open Dialogue on Air — featuring global experts discussing key trends in international development. Participants include award-winning Chinese sci-fi writer Chen Qiufan, Dr. Selina Neri of the Future Readiness Academy, Dr. Rais Hussin of EMIR Research (Malaysia), Prof. Wang Feng of UC Irvine, and global strategist Dr. Parag Khanna. First held in April 2025 at the Russia National Centre, the Open Dialogue brought together over 3,000 experts from dozens of countries. By presidential decree, it will now be held annually. Social Links Telegram: https://t.me/gowithrussia VK: https://vk.com/gowithrussia OK: https://ok.ru/gowithrussia DZen: https://dzen.ru/gowithrussia Contact for the media Brand: Russia National Centre Contact: Media team Email: Pressa@russia.ru Website: https://russia.ru Essay Submission: https://dialog.russia.ru/en/

January 30, 2026 - (SeaPRwire) - As regulatory frameworks for digital assets continue to mature across emerging markets, system security, risk management, and long-term operational stability have become key evaluation standards for crypto exchanges. Against this backdrop, Singapore-headquartered digital asset exchange Fexlon officially completed its global system launch in early 2026. Guided by its long-term vision, “Built on trust. Driven by the future.”, Fexlon positions itself as a builder of reliable and sustainable digital asset trading infrastructure. [caption id="attachment_5815" align="aligncenter" width="1696"] Fexlon officially launches its global digital asset trading platform.[/caption] Established in 2023, the Fexlon team includes core members with prior experience at leading digital asset exchanges, specializing in matching engine design, risk control systems, and platform operations. Before public launch, the platform underwent multiple rounds of internal testing and live trading environment validation, covering system stability, matching performance, and real-time risk response, providing foundational data for long-term operations. From a product strategy perspective, Fexlon has adopted a focused and disciplined development approach, currently prioritizing spot trading and derivatives (futures) trading as its core services. The platform operates on a self-developed trading system architecture, supported by distributed infrastructure and multi-region server deployment, reducing single-point failure risks and improving performance across diverse market conditions. In terms of security and risk management, Fexlon has implemented multi-layered controls across accounts, trading activities, and system permissions, complemented by an independent risk monitoring system designed to continuously detect and respond to abnormal trading behavior. To support user onboarding during the launch phase, Fexlon has introduced a limited-time participation campaign. New users who complete identity verification, deposits, and trading tasks are eligible to receive rewards and share a 100,000 USDT prize pool. The campaign emphasizes real trading experience and user feedback collection to further refine platform functionality and product performance. Currently, Fexlon is advancing technical deployment and compliance preparation across multiple key markets, including Indonesia, and will progressively align its operational framework with local regulatory requirements. Looking ahead, Fexlon will continue to build around the principles of trust, stability, and sustainability, strengthening its product capabilities and ecosystem development. Website: https://www.fexlon.com/ X: https://x.com/Fexlon_Research Telegram (Announcements): https://t.me/Fexlon_Announcement Telegram (Official Community): https://t.me/Fexlon_Official

In Collaboration with MAGO Moon Museum, Opening the “$VIVI RWA MARKET” Singapore – January 29, 2026 – (SeaPRwire) – LEGENDARY HUMANITY, a Singapore-based company listed on Gate.io, has announced the launch of the “$VIVI RWA MARKET,” a new Real World Asset (RWA) marketplace enabling the purchase of exhibited works by contemporary artist Mago Nagasaka. Developed in collaboration with the MAGO Moon Museum, this launch marks a significant milestone in LEGENDARY HUMANITY’s ongoing efforts to bridge cultural value and digital infrastructure through real-world assetization. Digitalizing Humanity’s Masterpieces Through AI 3D Scanning Technology – A New Purchasing Experience Led by LEGENDARY HUMANITY LEGENDARY HUMANITY PTE. LTD. (Headquarters: Singapore; CEO: Takamasa Suzuki) has officially opened the “$VIVI RWA MARKET,” an RWA marketplace where visitors can directly purchase artworks exhibited in the online museum “MAGO Moon Museum,” created by contemporary artist Shingo Nagasaka. This initiative forms part of the “VIVI PROJECT,” which aims to digitize humanity’s masterpieces into digital assets through high-precision, non-contact AI-integrated 3D scanning technology. Through this platform, visitors are able to acquire artworks they have viewed within MAGO Moon Museum as RWAs, enabling a deeper engagement with the artist’s worldview and creative philosophy. Overview Name: $VIVI RWA MARKET Opening Date: Thursday, January 29, 2026 URL: https://mondo.lhvivi.io/ About “$VIVI RWA MARKET” The “$VIVI RWA MARKET” is an RWA marketplace dedicated to the acquisition of artworks and is embedded within the online museum MAGO Moon Museum. Seamless Pathway from Viewing to Purchase Users can seamlessly transition from an artwork’s exhibition page to its corresponding RWA product page, creating a unified experience from online viewing to ownership. Integration of Physical and Digital Asset Design Each artwork includes the following structured information: Physical artwork details (size, materials, condition, provenance) High-resolution digital data generated through AI 3D scanning Artist profile and project background information along with other curated metadata. This structure allows users to acquire artworks with a proper understanding of their cultural and artistic value. Ecosystem Holding Functionality Acquired works will gradually gain viewing and management functionality within the VIVI ecosystem. While future integration with VIVI COiN is under consideration, the current initiative is focused solely on enhancing the preservation, appreciation, and understanding of the artworks. About LEGENDARY HUMANITY and the VIVI PROJECT LEGENDARY HUMANITY promotes the “VIVI PROJECT,” which digitizes legendary masterpieces created by humanity into digital assets using high-precision, non-contact, AI-integrated 3D scanning technology. The project operates under the vision of “Bringing the beauty of humanity to AI and the future.” Targeted assets include: Legendary fashion collections Historical architecture and cultural masterpieces Famous trading cards Artworks, including those exhibited at MAGO Moon Museum and other assets that can be described as humanity’s masterpieces. The VIVI PROJECT aims to: Digitize assets as digital cultural heritage Tokenize them as RWAs for global circulation Exhibit them in both online and physical museums thereby building new infrastructure that harmonizes cultural and economic value. NEXT SOCIETY (Gacha Location): https://nextsociety.lhvivi.io RWA Market Roadmap The launch of the “$VIVI RWA MARKET” represents the first phase of RWA market functionality within the VIVI PROJECT. Planned future developments include: VIVI FASHION (RWA for the fashion domain) VIVI TRADING CARD (RWA for the trading card domain) VIVI ART WORK (RWA for art collections) with future integration under consideration. About MAGO Moon Museum MAGO Moon Museum is an online museum created by contemporary artist Shingo Nagasaka, whose works explore themes related to electronic waste issues in Agbogbloshie, Ghana. The museum provides an online space to view Nagasaka’s representative works, including pieces created from discarded electronic components found in Ghanaian slums, as well as series examining the concept of “Sustainable Capitalism.” With the implementation of the “$VIVI RWA MARKET,” viewers can deepen their understanding of the artworks while acquiring pieces aligned with the artist’s philosophy in an appropriate and structured manner. Future Developments Building on this initiative, LEGENDARY HUMANITY plans to: Expand collaborations with masterpieces across different regions and genres Strengthen international networks with artists, collectors, and researchers Advance technological development for the preservation of cultural assets for future generations and continue developing as a platform that passes humanity’s masterpieces into the future through real-world assets. Media Contact Company Name: LEGENDARY HUMANITY PTE. LTD. Address: 105 Cecil St, The Octagon 24F-2, Singapore 06953 Representative: Takamasa Suzuki, LEGENDARY HUMANITY / VIVI PROJECT Public Relations Desk Email: info@lhvivi.com Related URL: $VIVI RWA MARKET https://mondo.lhvivi.io

Commences building an RWA (Real-World Asset) token economy Maximizing Value Through Digitalization Using Cutting-Edge 3D Scanning Technology “SCAI” and RWA Indexing New York, NY – January 20, 2026 – (SeaPRwire) – VIVI PROJECT (formerly LEGENDARY HUMANITY) announces a major update and rebranding. The project utilizes the latest 3D scanning technology “SCAI” to digitally archive humanity’s cultural heritage, providing training data for AI and building a new token economy based on RWA (Real World Assets). Background and Project Evolution Previously, “LEGENDARY HUMANITY” aimed to digitize humanity’s greatest masterpieces using cutting-edge technology, teaching AI about “humanity’s magnificence” to preserve its value for future generations. With this update, the project is renamed “VIVI PROJECT.” Moving beyond mere archiving, it will challenge the creation of new value in the Web3 era as an “RWA token project” building a unique economic ecosystem backed by real-world assets (RWA). The Four Pillars of the “RWA Ecosystem” Provided by VIVI PROJECT Digitization via High-Precision 3D Scanning Technology “SCAI:DIGITAL LUMINOUS Technology” Digitizing humanity’s treasures and providing them as AI training data. Merging human wisdom with technological evolution. Adding RWA Value to VIVI COiN: Centered around the project token “VIVI COiN,” we plan to link RWA held by collectors partnered with “VIVI PROJECT” to enhance the project’s value.By using “LEGENDARY masterpieces” whose value appreciates over time as the foundation for “VIVI COiN,” we build a stable value base. Hybrid Digital & Physical Museum Collected RWAs will be displayed in both digital museums and physical exhibition facilities. Trading via the marketplace will also be enabled, enhancing liquidity as an asset. VIVI DAO’s “Buy-Back & Burn” Model The governing body, “VIVI DAO,” will use exhibition and sales revenue to implement “Buy-Back” and “Burn” of VIVI COiN. This will increase the token’s scarcity and promote long-term value appreciation. Future Outlook: Global Collection Partnerships The VIVI PROJECT is advancing the networking of collections held by global asset owners. As a first step, we have initiated the following partnerships and negotiations: LA MUSEUM: Holds one of the world’s largest legendary fashion collections, including Yves Saint Laurent, Comme des Garçons, Worlds End, Alexander McQueen, John Galliano, and Madison Martin Margiela. Major Trading Card Company: Negotiations have commenced with the world’s largest trading asset company. This will integrate Real-World Assets (RWAs) from diverse genres like fashion, art, and hobbies into the project, rapidly expanding the ecosystem. VIVI PROJECT Overview VIVI PROJECT is a next-generation platform that preserves and utilizes humanity’s greatest masterpieces in both digital and physical realms through the fusion of culture and technology. By indexing RWA, it defines new asset value in the Web3 era. Official Website: https://lhvivi.com Contact for Inquiries Contact: VIVI PROJECT PR Department Email: press@lhvivi.com

Mexico City, Mexico – January 10, 2026 – (SeaPRwire) – Excent Capital has announced the launch of a new incentive program for its global partner network, offering exclusive experiences connected to the 2026 World Cu as part of its ongoing commitment to long-term collaboration and partner engagement. The initiative is designed to recognise partner performance and strengthen relationships through experiences that go beyond traditional rewards. Depending on performance tiers, partners may qualify for packages that include match tickets, travel arrangements, accommodation, and curated experiences in the United States during the tournament. Rather than focusing solely on volume, the program is structured to encourage sustainable growth, strategic alignment, and continued collaboration between Excent Capital and its partners. The incentive tiers are linked to clearly defined performance benchmarks, ensuring transparency and consistency across regions. “We work very closely with our partners on a daily basis, and this initiative is a way to give something back that goes beyond numbers,” said Andrés Espinosa, Senior Business Development Manager at Excent Capital. The World Cup 2026 incentive program is open to eligible partners worldwide and will run until May 15. Participation details, performance criteria, and tier qualifications are communicated directly to partners through Excent Capital’s regional business development teams. About Excent Capital Excent Capital is a global trading broker offering access to a wide range of financial markets. Operating on proprietary, in-house developed technology, the company focuses on transparency, execution quality, and partner-driven growth, supporting partners through education, consistent market insight, and collaborative initiatives. Contact Information Organization: Excent Capital Contact Person: Ryccielli Ongaratto, Marketing Manager Email: support@excent.capital Website: https://excent.capital/

Thỏa thuận này nhằm mục đích cùng nhau thúc đẩy việc nâng cấp hệ thống Y tế quốc gia và phát triển lâu dài phúc lợi xã hội. Gần đây, công ty Fxlinq và chính phủ Việt Nam đã chính thức ký kết thỏa thuận hợp tác chiến lược cấp quốc gia. Thỏa thuận này thể hiện rằng cả hai bên sẽ tham gia vào hợp tác sâu rộng, có hệ thống, lâu dài và mang tính cấu trúc trong các lĩnh vực trọng điểm như xây dựng hệ thống Y tế quốc gia, cải thiện cơ chế phúc lợi xã hội và hiện đại hóa dịch vụ Y tế công cộng. Sự hợp tác này sẽ đặt nền tảng vững chắc cho sự phát triển ổn định kinh tế và sức khỏe xã hội của Việt Nam trong thập kỷ tới và những năm tiếp theo. Theo thỏa thuận, công ty Fxlinq sẽ phát huy tối đa thế mạnh toàn diện của mình trong xây dựng hệ thống chăm sóc sức khỏe số, công nghệ y tế, phân tích dữ liệu AI, mô hình quản lý y tế và thiết lập hệ thống dịch vụ tài chính y tế. Công ty sẽ hợp tác sâu rộng với Bộ Y tế Việt Nam và các cơ quan chính phủ liên quan để tham gia đầy đủ vào việc hoạch định và thực hiện chiến lược y tế quốc gia ở cấp cao. Sự hợp tác sẽ tập trung vào các lĩnh vực cốt lõi như xây dựng hệ thống phòng chống dịch bệnh, quản lý dài hạn các bệnh mãn tính, phổ biến giáo dục sức khỏe cho toàn dân, phân bổ nguồn lực y tế số, quản lý thống nhất và đánh giá rủi ro dữ liệu y tế, nhằm xây dựng một hệ thống y tế quốc gia hiện đại, hiệu quả cao, bền vững và toàn diện. Trong quá trình xây dựng hệ thống y tế, thỏa thuận chiến lược này cũng tích hợp rõ ràng hệ thống an sinh xã hội quốc gia vào khuôn khổ hợp tác quốc gia. Thông qua thiết kế thể chế phát triển đồng bộ "y tế + tài chính + công nghệ", mục tiêu là từng bước tối ưu hóa cơ cấu chi tiêu y tế hộ gia đình, giảm thiểu tác động của các rủi ro sức khỏe đột xuất đến tài chính hộ gia đình, và liên tục nâng cao khả năng đảm bảo an ninh y tế của người dân cũng như năng lực chống chịu rủi ro tổng thể của các gia đình, từ đó tạo nền tảng vững chắc cho sự ổn định xã hội, kiểm soát tài chính và tăng trưởng kinh tế bền vững lâu dài. Các bộ ngành liên quan Chính phủ sẽ cung cấp hướng dẫn chính sách thường xuyên, hỗ trợ thể chế và đảm bảo nguồn lực cho hợp tác chiến lược này, đồng thời thiết lập cơ chế hợp tác liên ngành để thực hiện, giám sát và đánh giá nhằm đảm bảo việc thực hiện thỏa thuận một cách có trật tự, tiến độ dự án được theo dõi và kết quả có thể định lượng. Cơ chế này sẽ đẩy nhanh hiệu quả việc thực hiện các dự án chiến lược, đảm bảo các chính sách y tế và sinh kế quốc gia thực sự mang lại lợi ích cho mọi tầng lớp xã hội. Dựa trên phân tích dữ liệu đáng tin cậy và tính toán mô hình thống kê dài hạn, với việc tiếp tục thúc đẩy chiến lược này, bắt đầu từ năm 2031, dự kiến mức độ thể chất và sức khỏe tổng thể của người dân Việt Nam sẽ có sự cải thiện về cấu trúc, đồng thời năng lực đảm bảo sức khỏe gia đình và ổn định kinh tế cũng sẽ tăng lên. Quyết định này không chỉ giúp cải thiện toàn diện chất lượng cuộc sống của người dân mà còn nâng cao đáng kể chất lượng nguồn nhân lực quốc gia trong trung và dài hạn, tạo nền tảng lành mạnh và bền vững hơn cho phát triển kinh tế và quản trị xã hội. Quan hệ đối tác chiến lược giữa công ty Fxlinq và Bộ Y tế Việt Nam cùng các cơ quan chính phủ liên quan là một dự án hệ thống y tế và sinh kế cấp quốc gia hướng tới tương lai. Hai bên nhất trí tiếp tục tăng cường hợp tác và thúc đẩy số hóa, chuẩn hóa, tài chính hóa và khả năng nhân rộng các kết quả y tế, tạo nền tảng vững chắc cho việc xây dựng môi trường sống quốc gia an toàn hơn, ổn định hơn, khỏe mạnh hơn và bền vững hơn.

The agreement aims to jointly promote the upgrade of the national healthcare system and the long-term development of social welfare. Recently, Fxlinq and the Government of Vietnam officially signed this national-level strategic cooperation agreement. The agreement indicates that both parties will engage in deep, systematic, long-term, and structured cooperation in key areas such as building the national healthcare system, improving social welfare mechanisms, and modernizing public healthcare services. This collaboration will lay a solid foundation for Vietnam’s stable economic development and social health over the next decade and beyond. Under the agreement, Fxlinq will fully leverage its comprehensive strengths in digital healthcare system development, medical technology, AI data analytics, healthcare management models, and the establishment of medical financial service systems. The company will collaborate closely with the Ministry of Health of Vietnam and other relevant government agencies to fully participate in the planning and implementation of the national healthcare strategy at a high level. The cooperation will focus on core areas such as building disease prevention systems, long-term management of chronic diseases, nationwide health education, allocation of digital healthcare resources, unified management and risk assessment of healthcare data, aiming to build a modern, highly efficient, sustainable, and comprehensive national healthcare system. In the process of building the healthcare system, this strategic agreement also explicitly integrates the national social security system into the framework of national cooperation. Through the synchronized institutional design of “healthcare + finance + technology,” the goal is to gradually optimize household healthcare expenditure structures, minimize the impact of sudden health risks on family finances, and continuously enhance people’s healthcare security as well as families’ overall risk resilience, thereby creating a solid foundation for social stability, financial control, and long-term sustainable economic growth. Relevant government ministries will provide regular policy guidance, institutional support, and resource assurance for this strategic cooperation, while establishing an interdepartmental cooperation mechanism to implement, monitor, and evaluate the agreement to ensure orderly execution, track project progress, and quantify outcomes. This mechanism will accelerate the effectiveness of strategic projects, ensuring that national healthcare and livelihood policies genuinely benefit all social strata. Based on reliable data analysis and long-term statistical modeling, with continued promotion of this strategy, starting from 2031, the overall physical health and wellness of the Vietnamese population is expected to improve structurally, while the capacity to ensure family health and economic stability will also increase. This decision will not only comprehensively improve people’s quality of life but also significantly enhance the quality of the national workforce in the medium and long term, creating a healthier and more sustainable foundation for economic development and social governance. The strategic partnership between Fxlinq and the Ministry of Health of Vietnam, along with other relevant government agencies, is a national-level healthcare and livelihood project oriented toward the future. Both parties have agreed to continue strengthening cooperation and promoting the digitization, standardization, financialization, and scalability of healthcare outcomes, laying a solid foundation for building a safer, more stable, healthier, and more sustainable national living environment.

New York, NY – December 26, 2025 – (SeaPRwire) – Taxinexo, a U.S.-based autonomous vehicle operator, has entered a new phase of large-scale commercial deployment after nearly five years of continuous operation in the United States. Leveraging its mature Level 4 autonomous driving technology and proven operational capabilities, the company has expanded multi-scenario services across several U.S. states, positioning itself as a representative case of how federal and state policy coordination is accelerating the commercialization of autonomous driving in the U.S. smart mobility sector. Since its inception, Taxinexo’s growth trajectory has been deeply intertwined with the US autonomous driving industry’s policy support system. The US federal government, through national strategic documents such as the Comprehensive Autonomous Vehicle Initiative, has established a development orientation of “safety first, encouraging innovation,” providing companies with a flexible regulatory environment—including simplified administrative exemption procedures for autonomous vehicles, allowing steering wheel-less and pedal-less vehicles that meet technical standards to be tested and operated on public roads, significantly lowering the policy threshold for companies to iterate their technology. Meanwhile, the Inflation Reduction Act’s tax credit of up to $7,500 per vehicle for Level 3 and above autonomous driving vehicles further assisted Taxinexo in completing its R&D investment and fleet expansion, enabling it to achieve large-scale commercial operation in multiple states across the US. This has allowed it to accumulate millions of kilometers of real-world road operation data and build an operational network covering diverse scenarios such as urban main roads, business parks, and commuter shuttles. In an interview with this newspaper, Taxinexo’s Global Marketing Head stated, “The policy support in the US over the past five years has provided us with an excellent development platform. From technology R&D to commercialization, the flexible regulatory environment and precise policy support have allowed us to accumulate core capabilities to handle complex scenarios. In the future, we will continue to leverage local policy advantages, deepen our diversified scenario operation layout, and help promote the US autonomous driving industry towards a more efficient and safer stage.” Data shows that the US autonomous driving industry is rapidly expanding, with leading companies continuously increasing their fleet sizes and weekly order volume exceeding hundreds of thousands, indicating a broad commercial prospect for the industry. Taxinexo reportedly plans to further expand its service coverage in the United States based on its existing operations, focusing on high-frequency travel scenarios such as airport shuttles and intercity commuting, and will continue to increase investment in technology research and development to promote the iterative upgrade of its autonomous driving system. In the future, its large-scale operational experience may provide a replicable practice model for the intelligent transportation upgrades of more cities in the United States. Social Links Telegram: https://t.me/taxinexo X: https://x.com/taxinexo Facebook: https://www.facebook.com/profile.php?id=61585301312596 Instagram: https://www.instagram.com/taxinexo LinkedIn: https://www.linkedin.com/company/taxinexo/ YouTube: https://www.youtube.com/@taxinexo Media contact Brand: Taxinexo Contact: Media team Email: support@taxinexo.com Website: https://www.taxinexo.com

The King of the Monsters Becomes a Cinematic Welcome and Farewell, Showcasing Japanese Entertainment to Millions of International Travelers at Japan’s Global Gateway Singapore – December 23, 2025 – (SeaPRwire) – The HANEDA GODZILLA GLOBAL PROJECT officially launched a mega-scale initiative to broadcast Japanese entertainment to the world from Haneda Airport, through the collaboration of three companies: Toho Co., Ltd., Japan Airport Terminal Co., Ltd., and Tokyo International Airport Terminal Corporation. Under the theme “Godzilla welcomes all visitors to Japan and sees them off as they depart,” a colossal Godzilla statue, approximately 40 meters long and 9 meters tall, has been revealed inside Japan’s international gateway at Haneda Airport Terminal 3. Modeled after the original Godzilla, the monument surpasses the size of existing indoor installations and is designed to be viewed from multiple angles throughout Terminal 3. Additional installations in the area include Godzilla: The Great Monster Advance Picture Scroll in the arrival lobby and a standing statue from Godzilla Minus One that will be installed on December 3, further expanding the presence of the popular monster across arrivals and departures. To commemorate the completion of the world’s largest indoor Godzilla monument, a special announcement event was held at Haneda Airport, featuring remarks from notable guests. This consisted of Keiji Ota, Senior Managing Executive Officer and Chief Godzilla Officer (CGO) of Toho Co., Ltd.; Masatoshi Akahori, President and Representative Director of Tokyo International Air Terminal Corporation; and special guest actress Riko Fukumoto, ambassador for the “Godzilla The Ride” attraction at Seibuen Amusement Park. All of the guest speakers reflected on the cultural significance of the six-year project and Godzilla’s role as a global symbol of Japanese entertainment. As travel ramps up for the new year, the HANEDA GODZILLA GLOBAL PROJECT is set to leave a lasting impression on millions of international travelers passing through Terminal 3 with an encounter with one of Japan’s most iconic cultural symbols. The completion announcement event was held on Friday, December 19, with public installations opening in conjunction with year-end and New Year travel, and additional displays debuting beginning December 23. The unveiling was held at Haneda Airport Terminal 3 in Tokyo, Japan spanning both the departure and arrival lobbies at Japan’s primary international gateway. About TOHO Co., Ltd. TOHO Co., Ltd. is a leading Japanese entertainment company founded in 1932. Its four main business pillars are the cinema business, which includes production, distribution and exhibition; the theatrical business, which includes production and exhibition; the anime business, which has been expanding globally in recent years; and the real estate business, which focuses on development in urban areas. TOHO’s worldwide acclaimed works include theatrical films such as the “Godzilla” series and “Seven Samurai” directed by Akira Kurosawa, and TV anime series such as “My Hero Academia” and “Jujutsu Kaisen”. These anime series are produced and distributed through the TOHO animation label, and are delivered to a wide range of audiences around the world. Media Contact TOHO Entertainment Asia hello@tohoea.com.sg

New York, NY – December 23, 2025 – (SeaPRwire) – Holiverse, a biotech platform, has begun active development of a decentralized AI device designed to operate entirely offline without cloud dependency. The device will embed private artificial intelligence directly on hardware, eliminating the need to transmit personal data to external servers. According to the company, this approach addresses growing concerns about data sovereignty, privacy erosion and the concentration of AI processing power in centralized platforms. “We have conflated intelligence with centralization,” said Lado Okhotnikov, founder of Holiverse. “We built these vast, brilliant minds and asked them to solve our problems. But in doing so, we outsourced our sovereignty.” The Holiverse decentralized AI initiative targets three key capabilities: On-device processing: All data remains in a closed loop on the user’s hardware Offline functionality: Intelligence operates without internet connectivity Hyper-personalization: Models tuned to individual biological and behavioral data “This is undoubtedly a complex and resource-intensive process, and we are engaging some of the leading AI specialists,” Okhotnikov added. “This technology has the potential to significantly reduce the risks associated with AI and make interaction with it truly personal.” Holiverse expects to present initial developments publicly in the coming months. About Holiverse Holiverse is a biotech platform that integrates human biology and advanced technology. Founded by Lado Okhotnikov, the company creates holistic health solutions through personalized, data-driven approaches. Learn more at holiverse.ai. Social Links X: https://x.com/Holiverse Telegram: https://t.me/holiverse_ENG Media Contact Brand: Holiverse Contact: Media team Email: mailbox@holiverse.ai Website: https://holiverse.ai

Seoul, Korea – December 23, 2025 – (SeaPRwire) – HTM Korea, a Korean fire-safety technology company, announced the global expansion of its innovative automatic fire-suppression product line, CERA+, designed to prevent electrical fires in outlets and distribution boards. The company has rapidly grown within the domestic market through public procurement channels, supplying products to government agencies, educational institutions, and major industrial clients. CERA+ is a compact fire-suppression patch that activates automatically when an electrical hotspot occurs. Containing a certified clean-agent extinguishing compound, the patch bursts at a specific temperature and releases the agent to suppress flames at the earliest stage. The product has received official KFI (Korea Fire Institute) type approval, along with reliability tests such as temperature, humidity, and durability evaluations. HTM Korea currently offers outlet-type patches and distribution-board models in 20L, 40L, and 80L capacities. The company is accelerating its entry into Southeast Asia, the Middle East, and the United States, supported by growing demand from data centers, residential complexes, and industrial facilities. “As electrical fire risks continue to rise worldwide, we aim to provide simple but highly effective protection that any facility can adopt easily,” said a company representative. “We will continue expanding our product line and strengthening global partnerships.” Media contact Company: HTM Korea Co., Ltd. Contact: Su Hyeon Oh Phone: +82-10-3504-2913 Email: cera@cera.krWebsite: https://www.cera.kr